(Total Views: 360)
Posted On: 02/27/2020 2:16:41 PM
Post# of 149086
Docj,
The terms with China are not that good, appart from that we already have the product (no need to develop anything). Is matter of demonstrating that it works and hallas:
The terms of the contract, which have been agreed to in writing by both parties, include an upfront payment of $1 million to initiate the project work in the United States, a $5 million licensing fee for the Ii-Key technology, payment by the Chinese consortium for all costs and expenses related to the development of a COVID-19 vaccine, and a 20% royalty on each dose of vaccine produced.
The issue here is that we already have a deal (not sure if it is exclusive or not).
The terms with China are not that good, appart from that we already have the product (no need to develop anything). Is matter of demonstrating that it works and hallas:
The terms of the contract, which have been agreed to in writing by both parties, include an upfront payment of $1 million to initiate the project work in the United States, a $5 million licensing fee for the Ii-Key technology, payment by the Chinese consortium for all costs and expenses related to the development of a COVID-19 vaccine, and a 20% royalty on each dose of vaccine produced.
The issue here is that we already have a deal (not sure if it is exclusive or not).
(0)
(0)Scroll down for more posts ▼
